ATE552842T1 - Verwendung von plasminogen zur wundheilung - Google Patents

Verwendung von plasminogen zur wundheilung

Info

Publication number
ATE552842T1
ATE552842T1 AT06126236T AT06126236T ATE552842T1 AT E552842 T1 ATE552842 T1 AT E552842T1 AT 06126236 T AT06126236 T AT 06126236T AT 06126236 T AT06126236 T AT 06126236T AT E552842 T1 ATE552842 T1 AT E552842T1
Authority
AT
Austria
Prior art keywords
wound healing
plasminogen
healing
relates
tympanic membrane
Prior art date
Application number
AT06126236T
Other languages
English (en)
Inventor
Tor Ny
Jinan Li
Sten Hellstroem
Per-Olof Eriksson
Original Assignee
Omnio Healer Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omnio Healer Ab filed Critical Omnio Healer Ab
Application granted granted Critical
Publication of ATE552842T1 publication Critical patent/ATE552842T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacture Of Motors, Generators (AREA)
  • Enzymes And Modification Thereof (AREA)
AT06126236T 2001-09-06 2002-09-06 Verwendung von plasminogen zur wundheilung ATE552842T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31764301P 2001-09-06 2001-09-06

Publications (1)

Publication Number Publication Date
ATE552842T1 true ATE552842T1 (de) 2012-04-15

Family

ID=23234611

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06126236T ATE552842T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur wundheilung
AT02797695T ATE348631T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02797695T ATE348631T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen

Country Status (9)

Country Link
US (3) US7067492B2 (de)
EP (2) EP1790354B1 (de)
CN (2) CN1961958B (de)
AT (2) ATE552842T1 (de)
AU (1) AU2002361878A1 (de)
DE (1) DE60216939T2 (de)
DK (2) DK1427440T3 (de)
ES (2) ES2387797T3 (de)
WO (1) WO2003020297A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
AU2006265601A1 (en) * 2005-06-30 2007-01-11 Anthrogenesis Corporation Repair of tympanic membrane using placenta derived collagen biofabric
WO2007106536A2 (en) * 2006-03-14 2007-09-20 Oregon Health & Science University Methods for producing an immune response to tuberculosis
WO2008021391A1 (en) 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
AU2007290882B2 (en) * 2006-08-28 2013-02-21 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
CA2662101C (en) * 2006-08-28 2015-07-07 Omnio Healer Ab Candidates against infection
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
AU2007318210B2 (en) 2006-10-06 2014-02-20 Celularity Inc. Native (telopeptide) placental collagen compositions
US9174042B2 (en) 2007-05-25 2015-11-03 Empi, Inc. Wound healing electrode set
GB2450747A (en) * 2007-07-06 2009-01-07 Univ Sheffield Treatment of sensorineural hearing loss
EP2249863A4 (de) * 2008-01-22 2011-12-28 Omnio Healer Ab Verfahren zur verbesserung der wundheilung
RU2432397C2 (ru) * 2009-11-24 2011-10-27 Федеральное государственное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "РКНПК" Минздравсоцразвития России) РЕКОМБИНАНТНЫЙ ПОЛИПЕПТИД СО СВОЙСТВАМИ ПЛАЗМИНОГЕНА ЧЕЛОВЕКА ПРЕВРАЩАТЬСЯ ПРИ АКТИВАЦИИ В ПЛАЗМИН, КОТОРЫЙ КАТАЛИЗИРУЕТ РАСЩЕПЛЕНИЕ ФИБРИНА, ФРАГМЕНТ ДНК, КОДИРУЮЩИЙ ПОЛИПЕПТИД, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК ДЛЯ ЭКСПРЕССИИ ПОЛИПЕПТИДА И ТРАНСФОРМИРОВАННАЯ КЛЕТКА Escherichia coli - ПРОДУЦЕНТ ПОЛИПЕПТИДА
RU2432396C2 (ru) * 2009-11-24 2011-10-27 Федеральное государственное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "РКНПК" Минздравсоцразвития России) РЕКОМБИНАНТНЫЙ ПОЛИПЕПТИД СО СВОЙСТВАМИ ПЛАЗМИНОГЕНА ЧЕЛОВЕКА ПРЕВРАЩАТЬСЯ ПРИ АКТИВАЦИИ В ПЛАЗМИН, КОТОРЫЙ КАТАЛИЗИРУЕТ РАСЩЕПЛЕНИЕ ФИБРИНА, ФРАГМЕНТ ДНК, КОДИРУЮЩИЙ ПОЛИПЕПТИД, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК ДЛЯ ЭКСПРЕССИИ ПОЛИПЕПТИДА И ТРАНСФОРМИРОВАННАЯ КЛЕТКА Escherichia coli - ПРОДУЦЕНТ ПОЛИПЕПТИДА
PT2996709T (pt) 2013-05-15 2020-07-14 Univ Leland Stanford Junior Modulação da atividade do fator de crescimento epidérmico de ligação à heparina para cicatrização da membrana timpânica
TWI801331B (zh) * 2015-11-03 2023-05-11 美商波麥堤克生物治療股份有限公司 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法
TW201722464A (zh) * 2015-11-10 2017-07-01 波麥堤克生化科學有限公司 用於傷口癒合之纖維蛋白溶酶原給藥方案
JP2019500426A (ja) * 2015-12-18 2019-01-10 タレンゲン インターナショナル リミティッドTalengen International Limited 糖尿病網膜症を予防または治療するための方法
CA3008466C (en) * 2015-12-18 2023-06-20 Talengen International Limited Method for preventing or treating radiation and chemical damage
WO2017101871A1 (zh) 2015-12-18 2017-06-22 深圳瑞健生命科学研究院有限公司 一种预防和治疗心血管病的新方法
EP3395354B1 (de) 2015-12-18 2024-05-22 Talengen International Limited Plasminogen zur behandlung von diabetischer nephropathie
TWI653981B (zh) * 2015-12-18 2019-03-21 深圳瑞健生命科學硏究院有限公司 Use of plasminogen for the preparation of a medicament for preventing or treating a condition associated with diabetic nerve injury
EP3395355B1 (de) 2015-12-18 2026-03-04 Talengen International Limited Plasminogen zur behandlung von zervixerosion
TWI674903B (zh) * 2016-09-26 2019-10-21 國立陽明大學 製備改良豬血漿纖連蛋白以增強傷口癒合之應用
WO2018107701A1 (zh) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种新的降血糖和提高糖耐量的药物
JP7213552B2 (ja) 2016-12-15 2023-01-27 タレンゲン インターナショナル リミテッド 肝の繊維化を予防及び治療するための方法
CN108210897A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 预防和治疗肺纤维化的药物及其用途
CN108210901A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 一种新的降血糖和提高糖耐量的药物
TWI750189B (zh) 2016-12-15 2021-12-21 大陸商深圳瑞健生命科學研究院有限公司 一種治療冠狀動脈粥樣硬化及其併發症的方法
TWI677348B (zh) * 2016-12-15 2019-11-21 大陸商深圳瑞健生命科學研究院有限公司 一種改善心臟病變的方法
JP7168990B2 (ja) 2016-12-15 2022-11-10 タレンゲン インターナショナル リミテッド 肥満症を予防および治療するための方法および薬物
CA3067890A1 (en) 2017-06-19 2018-12-27 Talengen International Limited Method for regulating and controling glp-1/glp-1r and drug
CA3196851A1 (en) * 2020-11-25 2022-06-02 Grifols Worldwide Operations Limited Wound healing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI915149A0 (fi) * 1989-05-01 1991-10-31 Univ Notre Dame Du Lac Foerfarande och material foer expression av humant plasminogen i ett eukaryotiskt cellsystem som saknar en laegesspecifik plasminogenaktivator.
US6559119B1 (en) * 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
DE69528573T2 (de) 1995-01-27 2003-06-18 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno, Den Haag/S'gravenhage Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung
EP0830381A4 (de) 1995-06-09 2000-11-22 William N Drohan Chitinhydrogele, herstellungsverfahren und anwendung
US6043407A (en) 1997-07-29 2000-03-28 Warner-Lambert Company Debridement pad
AU1731300A (en) * 1998-11-25 2000-06-13 Bristol-Myers Squibb Company Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
WO2000061179A1 (en) * 1999-04-14 2000-10-19 Karolinska Innovations Ab Kringle domains of plasminogen, capable of modulating angiogenesis in vivo
US7067492B2 (en) 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme

Also Published As

Publication number Publication date
DK1427440T3 (da) 2007-04-30
AU2002361878A1 (en) 2003-03-18
CN1961958A (zh) 2007-05-16
WO2003020297A2 (en) 2003-03-13
EP1790354B1 (de) 2012-04-11
US20070041962A1 (en) 2007-02-22
ES2387797T3 (es) 2012-10-01
ES2279001T3 (es) 2007-08-16
EP1790354A3 (de) 2007-10-24
US7067492B2 (en) 2006-06-27
DK1790354T3 (da) 2012-07-23
WO2003020297A3 (en) 2003-10-09
US20030147879A1 (en) 2003-08-07
US20080090751A1 (en) 2008-04-17
CN1585649A (zh) 2005-02-23
DE60216939D1 (de) 2007-02-01
DE60216939T2 (de) 2007-10-04
US8679482B2 (en) 2014-03-25
CN1289145C (zh) 2006-12-13
EP1427440B1 (de) 2006-12-20
WO2003020297A8 (en) 2004-07-08
EP1427440A2 (de) 2004-06-16
EP1790354A2 (de) 2007-05-30
CN1961958B (zh) 2011-05-18
US8637010B2 (en) 2014-01-28
ATE348631T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
ATE348631T1 (de) Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE376446T1 (de) Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung
DE60137430D1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
EP1324780A4 (de) Methoden zur behandlung von herzarrhythmie
DE60101669D1 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
DE60214477D1 (de) Implantat zur Regeneration von Knorpelgewebe
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
ATE452655T1 (de) Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung
ATE515268T1 (de) Verwendung von op-1 zur behandlung von knorpeldefekten
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen
DE50313329D1 (de) 1-phenyl-2-dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz
DE60325496D1 (de) Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE275580T1 (de) Verfahren zur induktion der herstellung von wachstumsfaktoren
ATE314066T1 (de) Verwendung von buprenorphin zur therapie der harninkontinenz
ATE324905T1 (de) Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall
ATE353666T1 (de) Verwendung von aktiviertem gerinnungsfaktor vii zur behandlung von durch thrombolytische therapie-induzierten wichtigen blutungen